Paper40906309
The Effect of Multiple Oral Doses of a Glycine Transporter 1 Inhibitor, Iclepertin (BI 425809), on the Steady-state Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel: a Phase I Clinical Trial in Healthy Females.
Madari S and 4 others. Clin Drug Investig, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The Effect of Multiple Oral Doses of a Glycine Transporter 1 Inhibitor, Iclepertin (BI 425809), on the Steady-state Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel: a Phase I Clinical Trial in Healthy Females. Papers, record 40906309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40906309
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The Effect of Multiple Oral Doses of a Glycine Transporter 1 Inhibitor, Iclepertin (BI 425809), on the Steady-state Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel: a Phase I Clinical Trial in Healthy Females.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ethinyl Estradiol | Major topic |
| Levonorgestrel | Major topic |
| Contraceptives, Oral, Combined | Major topic |
| Glycine Plasma Membrane Transport Proteins | Major topic |
| Humans | |
| Female | |
| Adult | |
| Young Adult | |
| Adolescent | |
| Drug Interactions | |
| Healthy Volunteers | |
| Administration, Oral | |
| Drug Combinations | |
| Piperazines | |
| Sulfones | |
| Liver-Specific Organic Anion Transporter 1 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1346-0036 | Boehringer Ingelheim | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05613777 | A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood | Derived from the trial | Yes |
Source ClinicalTrials.gov
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31664453 | Schizophrenia-An Overview. | JAMA Psychiatry | 2020 | https://conductscience.org/library/papers/31664453 | PubMed |
| 2 | 36971864 | Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia. | Eur Arch Psychiatry Clin Neurosci | 2023 | https://conductscience.org/library/papers/36971864 | PubMed |
| 3 | 17253885 | Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug. | Clin Pharmacokinet | 2007 | https://conductscience.org/library/papers/17253885 | PubMed |
| 4 | 29076028 | Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study. | Eur J Drug Metab Pharmacokinet | 2018 | https://conductscience.org/library/papers/29076028 | PubMed |
| 5 | 25103208 | The impact of aging, cognition, and symptoms on functional competence in individuals with schizophrenia across the lifespan. | Schizophr Bull | 2015 | https://conductscience.org/library/papers/25103208 | PubMed |
| 6 | 11849197 | The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity. | Br J Clin Pharmacol | 2002 | https://conductscience.org/library/papers/11849197 | PubMed |
| 7 | 25583246 | The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. | Schizophr Res | 2015 | https://conductscience.org/library/papers/25583246 | PubMed |
| 8 | 29056491 | Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults. | Schizophr Res | 2018 | https://conductscience.org/library/papers/29056491 | PubMed |
| 9 | 36700734 | Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates: Findings From In Vitro Analyses and an Open-Label, Single-Sequence Phase I Study. | J Clin Psychopharmacol | 2023 | https://conductscience.org/library/papers/36700734 | PubMed |
| 10 | 21253021 | Glycine transport inhibitors for the treatment of schizophrenia. | Open Med Chem J | 2010 | https://conductscience.org/library/papers/21253021 | PubMed |
| 11 | 32110026 | Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. | Neuropsychiatr Dis Treat | 2020 | https://conductscience.org/library/papers/32110026 | PubMed |
| 12 | 33167674 | Contraception for Women With Psychiatric Disorders. | Am J Psychiatry | 2021 | https://conductscience.org/library/papers/33167674 | PubMed |
| 13 | 33343262 | The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. | Focus (Am Psychiatr Publ) | 2020 | https://conductscience.org/library/papers/33343262 | PubMed |
| 14 | 22299599 | Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women. | Br J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22299599 | PubMed |
| 15 | 30136756 | Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies. | Clin Transl Sci | 2018 | https://conductscience.org/library/papers/30136756 | PubMed |
| 16 | 30127324 | Current Concepts and Treatments of Schizophrenia. | Molecules | 2018 | https://conductscience.org/library/papers/30127324 | PubMed |
| 17 | 26038220 | Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia. | Qual Life Res | 2015 | https://conductscience.org/library/papers/26038220 | PubMed |
| 18 | 33610228 | Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. | Lancet Psychiatry | 2021 | https://conductscience.org/library/papers/33610228 | PubMed |
| 19 | 31415864 | Pathways to functional outcomes in schizophrenia spectrum disorders: Meta-analysis of social cognitive and neurocognitive predictors. | Neurosci Biobehav Rev | 2019 | https://conductscience.org/library/papers/31415864 | PubMed |
| 20 | 11012556 | Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation. | Br J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/11012556 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 |
Source NCBI Gene
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| LEVONORGESTREL | CHEMBL1389 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1389 | ChEMBL |
| ICLEPERTIN | CHEMBL5314576 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL5314576 | ChEMBL |
| ETHINYL ESTRADIOL | CHEMBL691 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL691 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Cited by
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40906309
GET https://conductscience.org/api/papers/v1/40906309/references?page=2